Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 32
|
ECE2013
|
Next issue
15th European Congress of Endocrinology
All volumes
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
eposters
Abstracts
Contents
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Regulation of aldosterone secretion: from physiology to disease
ea0032eje1
The European Journal of Endocrinology Prize Winner
ea0032eje1biog
The Geoffrey Harris Prize Lecture
Speakers, cross-talk and chatter in reproductive neuroendocrinology
ea0032gh1
The Geoffrey Harris Prize Winner
ea0032gh1biog
Plenary Lectures
Nutrient-sensing pathways in ageing
Nutrient-sensing pathways and ageing
ea0032pl1
NET Management
Neuroendocrine tumour management
ea0032pl2
Changing character of thyroid cancer
Changing character of thyroid cancer
ea0032pl3
Fondation IPSEN 2013 Endocrine Regulations Prize
Nuclear receptor 'master' coactivators of physiology and pathology
ea0032pl4
Preventing vascular complications of diabetes
Prevention and treatment of renal and cardiovascular disease in diabetes: new aspects
ea0032pl5
The Ubiquitin System
Abstract unavailable
ea0032pl6
Aldosterone, Mineralocorticoid Receptors and Cardiovascular Risk: What's New?
Aldosterone, mineralocorticoid receptors and cardiovascular risk: what's new?
ea0032pl7
New genes and functions in reproduction
New genes and functions in reproduction
ea0032pl8
Human Brown Fat is on Fire
Human brown fat is on fire
ea0032pl9
Symposia
Metabolic surgery
New insights in obesity pathophysiology of metabolic surgery
ea0032s1.1
Abstract unavailable
ea0032s1.2
Abstract unavailable
ea0032s1.3
Cushing's Disease with negative pituitary imaging
Abstract unavailable
ea0032s2.1
Surgical approach to corticotroph adenomas poorly visible at preoperative imaging
ea0032s2.2
Medical approach to Cushing's disease: results of a French multicentre study
ea0032s2.3
Female reproduction
The transcription factor FOXL2 in ovarian physiology and pathology
ea0032s3.1
NR5A1/SF-1 and gonadal development and function
ea0032s3.2
Progestin action in the brain
ea0032s3.3
New advances in GPCRs in endocrinology
Abstract unavailable
ea0032s4.1
Biased agonism of the AT1 receptor: perspectives in drug discovery?
ea0032s4.2
G-protein-coupled receptor heteromers as new targets for drug development
ea0032s4.3
A guide through the labyrinth of neuroendocrine tumours
Tumor biology and classification of NET
ea0032s5.1
Nuclear medicine imaging of neuroendocrine tumours
ea0032s5.2
Abstract unavailable
ea0032s5.3
What's new in type 2 diabetes?
The impact of our genomes on metabolic health
ea0032s6.1
Insulin resistance and adipose tissue
ea0032s6.2
Mechanisms of [beta] cell failure in type 2 diabetes
ea0032s6.3
Translational aspects from comparative to clinical endocrinology
Brain aromatase and endocrine disruptors in zebrafish: from basic to applied research
ea0032s7.1
Abstract unavailable
ea0032s7.2
Peptide hormones and receptors: why so many?
ea0032s7.3
Action of glucocorticoids on bone
Glucocorticoid action on the skeleton
ea0032s8.1
Osteoporosis: now and the future
ea0032s8.2
Glucocorticoid-induced osteoporosis
ea0032s8.3
New data treatment of hyperglycemia
GLP-1 analogues
ea0032s9.1
Early insulin treatment in type 2 diabetes
ea0032s9.2
Ultra-long acting insulins
ea0032s9.3
Salt-water balance
Abstract unavailable
ea0032s10.1
Clinical aspects of diabetes insipidus and hyponatremia
ea0032s10.2
Antidiuresis: insights into the molecular regulation
ea0032s10.3
New mechanisms in SST analogue response
Functional relevance of truncated SST5 receptor variants
ea0032s11.1
Role of filamin A in dopamine and somatostatin receptor targeting in the pituitary
ea0032s11.2
Role of ERK in somatostatin receptor signalling
ea0032s11.3
Male reproductive endocrinology
Semaphorin 3A: a new gene involved in Kallmann syndrome
ea0032s12.1
Signal transduction in sperm functions
ea0032s12.2
Small RNAs in spermatogenesis
ea0032s12.3
Hormonal treatment in transition of patients with rare diseases (Supported by the
European Journal of Endocrinology
)
Hormonal treatment in transition of patients with Prader-Willi syndrome
ea0032s13.1
Transition of females with Turner syndrome
ea0032s13.2
Hormonal treatment of patients with Klinefelter syndrome during transition
ea0032s13.3
Clinical care of the pheochromocytoma patient
Clinical care of the pheochromocytoma patient
ea0032s14.1
Pheochromocytoma imaging
ea0032s14.2
Treatment of malignant pheochromocytomas and paragangliomas
ea0032s14.3
The Frail Male
Sarcopenia in men: the endocrine perspective
ea0032s15.1
Male osteoporosis
ea0032s15.2
Cognitive decline in male ageing
ea0032s15.3
Oncogenic signals in thyroid cancer - therapeutic prospects
BRAF
V600E
and PIK3CA
H1074R
cooperate to promote progression of anaplastic thyroid carcinoma in the mouse
ea0032s16.1
Abstract unavailable
ea0032s16.2
Oncogenic activation in thyroid cancer and response to radioiodine
ea0032s16.3
Medical treatment of endocrine malignancies - an update
Pituitary carcinoma
ea0032s17.1
Medical treatment of adrenocortical cancer
ea0032s17.2
Abstract unavailable
ea0032s17.3
PCOS
Environmental impact on the PCOS phenotype
ea0032s18.1
PCOS in adolescence: towards a therapy targeting adipose tissue
ea0032s18.2
The diagnosis of PCOS in adults: new biomarkers
ea0032s18.3
Recent advances in the molecular study of endocrine tumours: microRNAs and more
TGF-[beta] signaling and the microRNA machinery
ea0032s19.1
MicroRNAs in pituitary tumours
ea0032s19.2
MicroRNAs and gene expression patterns in adrenal tumours
ea0032s19.3
New mechanisms of energy balance
Abstract unavailable
ea0032s20.1
Programming of host metabolism by the gut microbiota
ea0032s20.2
Abstract unavailable
ea0032s20.3
Multi-centre pituitary studies
New classification of pituitary tumours based on the hypopronos database
ea0032s21.1
Lessons from the Liege Acromegaly Survey (LAS)
ea0032s21.2
Lessons from the European Cushing's registry (ERCUSYN)
ea0032s21.3
Improving diagnosis of primary aldosteronism
Genetics of primary aldosteronism
ea0032s22.1
Abstract unavailable
ea0032s22.2
Adrenal vein sampling
ea0032s22.3
Endocrine disruptors (Supported by
Endocrine Connections
)
Abstract unavailable
ea0032s23.1
Male reproductive health and endocrine disrupters
ea0032s23.2
Are structural analogs to bisphenol A a safe alternative?
ea0032s23.3
Redefining our understanding of the causes of obesity
Abstract unavailable
ea0032s24.1
Social stress, obesity and type 2 diabetes
ea0032s24.2
Ambient temperature and other environmental factors in obesity
ea0032s24.3
Rare metabolic bone disease
Paget's disease of bone: how to treat and monitor patients
ea0032s25.1
Osteogenesis imperfecta
ea0032s25.2
Abstract unavailable
ea0032s25.3
Novel technologies and inspiring ideas: From basic endocrine research to clinical practice (European Young Endocrine Scientists (EYES) Symposium)
Making a functional thyroid in a dish
ea0032s26.1
Dissecting androgen action: new clues from conditional knockout mice
ea0032s26.2
Abstract unavailable
ea0032s26.3
Steroids in obesity and metabolism
11[beta]-Hydroxystreroid dehydrogenase activity and obesity
ea0032s27.1
Metabolic control through glucocorticoid hormones
ea0032s27.2
Glucocorticoid-mediated fetal programming in humans
ea0032s27.3
Autoimmune endocrine disease - Old and new players
Autoimmune thyroid disease
ea0032s28.1
Autoimmune Addison's disease: new players in diagnosis and treatment
ea0032s28.2
Hypophysitis
ea0032s28.3
Management of thyroid nodules
Molecular analysis of FNAB material
ea0032s29.1
Diagnostic pitfalls in fine needle aspiration of thyroid nodules
ea0032s29.2
Follow-up of benign nodules
ea0032s29.3
Energy Status and pituitary function
Energy status and puberty: novel neuroendocrine regulatory mechanisms
ea0032s30.1
Energy status and glucocorticoid excess
ea0032s30.2
Energy status and GH/IGF1 axis
ea0032s30.3
Clinical impact of rare mutations in endocrinology
Does a new mutation always predict a new disease? Lessons from p27 mutations
ea0032s31.1
Old and new MEN1 mutations
ea0032s31.2
Genetic diagnosis of hereditary neuroendocrine syndrome in asyntomatic patients: clinical and prognostic implications
ea0032s31.3
Is diabetes a lipid disease?
Abstract unavailable
ea0032s32.1
Fatty liver disease
ea0032s32.2
Adipose tissue lipolysis and insulin sensitivity
ea0032s32.3
Meet the Expert Sessions
(1)
What systems biology can do for endocrine research?
ea0032mte1
Abstract unavailable
ea0032mte2
Insulin therapy
ea0032mte3
Abstract unavailable
ea0032mte4
Current guidelines for the classification of net
ea0032mte5
New immunotherapy approaches for Graves' orbitopathy
ea0032mte6
Abstract unavailable
ea0032mte7
Abstract unavailable
ea0032mte8
Abstract unavailable
ea0032mte9
Abstract unavailable
ea0032mte10
Abstract unavailable
ea0032mte11
Abstract unavailable
ea0032mte12
Hypogonadotropic hypogonadism
ea0032mte13
Abstract unavailable
ea0032mte14
Abstract unavailable
ea0032mte15
Diabetic foot disease for endocrinologists
ea0032mte16
JOE/JME Prize Presentation <emphasis role="italic">Sponsored by</emphasis><ulink url="http://jme.endocrinology-journals.org"><emphasis role="italic">Journal of Molecular Endocrinology</emphasis></ulink>
Enhancing radioiodine uptake in thyroid cancer
Enhancing radioiodine uptake in thyroid cancer
ea0032jp1
Endocrine Nursing Symposium
(1)
Pre- and post-operative care of the patient undergoing pituitary surgery
ea0032en1.1
Pituitary dynamic testing
ea0032en1.2
Abstract unavailable
ea0032en1.3
GH replacement in adults
ea0032en1.4
Abstract unavailable
ea0032en1.5
The role of the endocrine nurse in the care and treatment of children with congenital adrenal hyperplasia and in their transition to the adult service
ea0032en2.1
Management of CAH in adults
ea0032en2.2
A patient's perspective of CAH: the importance of care
ea0032en2.3
Abstract unavailable
ea0032en2.4
Abstract unavailable
ea0032en2.5
The endocrinology nursing in Denmark
ea0032en3.1
Incorporating research in to the role of the endocrine nurse: an example from my practice
ea0032en3.2
Competency framework for the endocrine clinical nurse specialist
ea0032en3.3
Abstract unavailable
ea0032en3.4
Abstract unavailable
ea0032en3.5
Oral Communications
Pituitary & Molecular Endocrinology
The consequences of changing endogenous GH/IGF1 levels on carcinogen-induced mammary gland tumorigenesis are dependent on metabolic status in mice
ea0032oc1.1
Involvement of the constitutive activity of the GHS-R1a (ghrelin G-protein coupled receptor) in the tumorigenesis of somatotroph adenomas
ea0032oc1.2
Heterodimerisation of FSH and LH receptors positively modulates the LH-induced signalling profile
ea0032oc1.3
BKM120, a pure PI3K inhibitor: a promising treatment for aggressive pituitary tumors or pituitary carcinomas
ea0032oc1.4
Differential effect of octreotide treatment on expression of sstr2a, 3 and 5 in somatotroph adenomas
ea0032oc1.5
Management of euvolemic hyponatremia attributed to SIADH in the hospital: interim results from a prospective, observational, multi-center, global registry
ea0032oc1.6
Bone & Calcium
Bone mass accrual following supplementation of vitamin D alone versus vitamin D+ calcium in underprivileged Indian premenarcheal girls
ea0032oc2.1
Influence of vitamin D and calcium on reproductive hormones: a study in a VDR-ablated male mouse model and 300 healthy men
ea0032oc2.2
Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series
ea0032oc2.3
Natural course of changes in bone mineral density after orthotopic liver transplantation: up to 5 years follow-up in a single centre
ea0032oc2.4
Genetic analysis of CDKN1B gene in familial primary hyperparathyroidism
ea0032oc2.5
Hypomineralized teeth as biomarkers of exposure to endocrine disruptors
ea0032oc2.6
Thyroid
Targeting of PATZ1 by miR-29b is a downstream effect of oncogenic Ras signalling in thyroid cells
ea0032oc3.1
Mitochondrial mass and function is regulated by PI3K signaling in thyroid cancer cells
ea0032oc3.2
SP600125, a new p53 selective anticancer drug: effects on poorly differentiated thyroid cancers
ea0032oc3.3
DNA methylation signatures identify biologically distinct thyroid cancer subtypes
ea0032oc3.4
Role of the calcium-calmodulin dependent kinase 2 in medullary thyroid carcinoma
ea0032oc3.5
Subclinical hyperthyroidism and risk of cardiovascular and all-cause mortality
ea0032oc3.6
Adrenal
Pre-clinical model detects castrate-resistant cancer repopulating cells in localised prostate tumours
ea0032oc4.1
Single nucleotide polymorphism array profiling of adrenocortical tumors: evidence for an adenoma carcinoma sequence?
ea0032oc4.2
Prognostic factors of advanced unresectable by stage III and IV ENS@T adrenocortical carcinomas (ACC)
ea0032oc4.3
Neuronal dysfunction in the hippocampi of cured Cushing's syndrome patients, detected by 1H-MR-spectroscopy
ea0032oc4.4
Influence of somatic mutations on the lateralization index of adrenal vein sampling in aldosterone producing adenomas
ea0032oc4.5
9-cis retinoic acid, a novel treatment option for adrenocortical cancer? in vitro and in vivo studies
ea0032oc4.6
Reproduction
BMP15-dependent gene-expression profiling in human granulosa cells
ea0032oc5.1
The (TAAAA)n polymorphism in the SHBG gene is related to prenatal androgenization of female fetus: possible implications of the developmental origin of metabolic disorders
ea0032oc5.2
Age-related hormonal and metabolic alterations in women with polycystic ovary syndrome (PCOS)
ea0032oc5.3
Influence of variants in the FSHB and FSHR gene on reproductive parameters in males and females
ea0032oc5.4
FSHB -211 and FSHR 2039 polymorphisms are associated with serum levels of FSH, AMH and age of pubertal onset in 78 healthy girls: a longitudinal cohort study
ea0032oc5.5
INSL3 in 268 male patients with congenital hypogonadotropic hypogonadism (CHH): effects of different modalities of hormonal treatment
ea0032oc5.6
Diabetes & Obesity
Type 2 diabetes risk alleles frequencies in the Portuguese population
ea0032oc6.1
Dissociation between high fat diet-induced obesity (DIO) and insulin resistance: lessons from AHNAK knockout mice
ea0032oc6.2
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men
ea0032oc6.3
Reduction of fat mass with the mTOR inhibitor, sirolimus, in humans: from transplantation to lipodystrophies
ea0032oc6.4
The role of costimulatory molecules B7.1 and B7.2 in obesity-related adipose tissue inflammation and liver steatosis
ea0032oc6.5
Serum- and glucocorticoid-regulated kinase 1 in obesity-related adipose tissue and peripheral inflammation
ea0032oc6.6
Nurse Posters
(1)
Pegvisomant home care program is likely to improve treatment compliance leading to rapid IGF1 control
ea0032n1
Psychiatric morbidity in pediatric patients after surgical remission of Cushing's disease: case presentations
ea0032n2
Living in the shadow and light: Iranian youths' response to diabetes-related stigma
ea0032n3
Nurse led telephone clinic: antenatal hypothyroidism
ea0032n4
Assessing treatment satisfaction, knowledge and adherence of patients attending a pituitary Nurse-led Clinic
ea0032n5
Poster Presentations
Adrenal cortex
Chronocort[reg], a multiparticulate modified release hydrocortisone formulation, shows dose linearity and twice daily dosing provides physiological cortisol exposure
ea0032p1
Impaired quality of life in CAH adults is associated with adiposity and insulin resistance
ea0032p2
Correlation between cell cycle, steroidogenesis and PKA RIA and RIIB subunits in adrenocortical tumors cells
ea0032p3
Long-term follow-up in adrenal incidentalomas: an Italian Multicentre Study
ea0032p4
The gene expression profile of cortisol secretion in adrenocortical adenomas
ea0032p5
Activation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion
ea0032p6
Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease
ea0032p7
Plasma metanephrine for assessing the selectivity of adrenal venous sampling
ea0032p8
Insulin sensitivity in patients with Addison's disease: a randomised cross-over trial comparing conventional glucocorticoid replacement therapy with continuous subcutaneous hydrocortisone infusion therapy.
ea0032p9
First phase insulin secretion is impaired by aldosterone excess in primary aldosteronism
ea0032p10
Molecular screening for personalized treatment approach in advanced adrenocortical cancer
ea0032p11
Abstract unavailable
ea0032p12
Detection of circulating tumor cells in adrenocortical carcinoma: a monocentric preliminary study
ea0032p13
New diagnostic methods for primary aldosteronism with specific antibodies
ea0032p14
[em]In vivo [em] and [em] in vitro[/em] evidence supporting SSTR/mTOR pathway targeting in adrenocortical cancer
ea0032p15
Mortality in long-term follow-up patients with progressively increased patterns of subclinical cortisol hypersecretion
ea0032p16
Role of adrenal vein sampling in primary aldosteronism: impact of different diagnostic criteria on subtype diagnosis
ea0032p17
The diagnosis of nonclassical congenital adrenal hyperplasia due to 21 hydroxylase deficiency in woman can be established by genetic testing or urine steroid profile analysis but not by ACTH stimulation test
ea0032p18
Genetic analysis does not confirm NCCAH in almost half of the women who had received this diagnosis: preliminary results of an audit
ea0032p19
Investigation of [beta]-catenin, N-cadherin, and E-cadherin expression in adrenocortical tumors
ea0032p20
Bilateral inferior petrosal sinus sampling in cushing's syndrome: comparison between an old and a new technique in naples experience
ea0032p21
21-hydroxylase and interferon omega autoantibodies in Turner syndrome
ea0032p22
Immunohistochemical markers of adrenal cortical tumors
ea0032p23
Management of Addison's disease patients using dual release hydrocortisone during periods of intercurrent illness
ea0032p24
Abstract unavailable
ea0032p25
Longitudinal assessment of adrenocortical responses to low-dose ACTH in critically ill septic patients
ea0032p26
Increasing prevalence of Addison's disease in Germany: health insurance data 2007-2011
ea0032p27
The role of late-night salivary cortisol measurement in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas
ea0032p28
Aldosterone measurement: performances of a new fully automated chemilunescence-based immunoassay
ea0032p29
Patients with Addison's disease have increased frequency of the metabolic syndrome: a case-control study
ea0032p30
Reliability of serum versus salivary cortisol in ACTH test
ea0032p31
Diagnostic performance of first line biochemical tests to differentiate ACTH-ectopic syndrome among ACTH dependent Cushing's syndrome
ea0032p32
Salivary cortisol is a useful tool to assess the immediate response to pasireotide in patients with Cushing's disease
ea0032p33
Male hypogonadism in Addison's disease - an under-recognized problem
ea0032p34
A national survey on the prevalence and treatment outcome of active Cushing's disease in Belgium
ea0032p35
More than two successive measurements of late-night salivary cortisol are needed to accurately diagnose early-stage post-surgical recurrence of Cushing's disease
ea0032p36
Adrenal venous sampling is mandatory and CT scan is unreliable for diagnosing unilateral primary hyperaldosteronism
ea0032p37
Endosonography-guided fine-needle aspiration biopsy in differential diagnosis of adrenal gland tumours - pilot study
ea0032p38
The Urinary Aldosterone in the Diagnosis of Primary Aldosteronism
ea0032p39
Autoimmune polyglandular syndrome on a cohort of patients with primary adrenocortical insufficiency
ea0032p40
Non-classic adrenal hyperplasia (NCAH) in patients with bilateral adrenal incidentally discovered tumors
ea0032p41
Effect of glucocorticoids treatment on anthropometric parameters and sexual maturation rating in salt wasting and simple virilizing forms of congenital adrenal hyperplasia in Pakistani boys
ea0032p42
Overt and ubclinical hypercortisolism in patients with diabetes mellitus and obesity
ea0032p43
Association of a variant of V281L of 21-hydroxylase gene CYP21A2 with simple virilizing and salt wasting types of CAH in Pakistani population
ea0032p44
Long-term efficacy of pasireotide in a patient with Cushing's disease and diabetes: results in the short term are not always predictive of long-term response
ea0032p45
Autonomous aldosterone secretion as a significant cause of arterial hypertension: the effectiveness of targeted therapy
ea0032p46
Cushing'S syndome: source of ectopic secretion of acth found after 20 years of follow-up
ea0032p47
Glucose tolerance in Cushing's disease
ea0032p48
European Adrenal Insufficiency Registry: a comparative observational study of glucocorticoid replacement therapy
ea0032p49
Oncocytic adrenal carcinoma with production of testosterone and cortisol: case report
ea0032p50
Prevalence of primary aldosteronism among hypertensive population in Trabzon City, Turkey
ea0032p51
Adrenal metastases: aetiolgies and outcome
ea0032p52
Adrenal inclusion in testicular: about six cases
ea0032p53
Hyperaldosteronism in patients with hyperparathyroidism: three cases
ea0032p54
Analyses of data of the patients with Cushing's disease with use of Moscow Region's database
ea0032p55
Evaluation of monitoring protocol for adrenal incidentalomas in our area
ea0032p56
Impact of antihypertensive drugs, sodium intake and potassium plasma concentrations on plasma aldosterone and plasma renin aktivity
ea0032p57
A case of Addison's disease caused by systemic disseminated tuberculosis: mimicking lymphoma on F-18 FDG PET-CT
ea0032p58
Cardiovascular risk in Cushing's syndrome
ea0032p59
Management of adrenal carcinoma in a tertiary center of Endocrinology in Romania
ea0032p60
Severe hyperglycemia due to cortisol producing adrenal carcinoma
ea0032p61
Metastatic adrenocortical carcinoma presenting with concomitant secretion of glucocorticoid, mineralocorticoid, androgen, and catecholamines: a case report
ea0032p62
Adrenal lymphoma: about two cases
ea0032p63
Hypercortisolism endogenous and pregnancy: a report of three cases
ea0032p64
Adrenal Medulla
Stud phenotypic study of paraganglioma extra surrenlien: about height cases
ea0032p65
Plasma free metanephrine and normetanephrine in chronic kidney disease patients
ea0032p66
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation
ea0032p67
Adrenal ganglioneuroma in a patient with a non-Hodgkin lymphoma
ea0032p68
Evaluation of patients with pheochromocytoma for 10 yearly period
ea0032p69
Bone and Osteoporosis
Bone loss in inflammation-mediated osteoporosis: a role for the P2[times]7 receptor?
ea0032p70
Abstract unavailable
ea0032p71
Circadian rhythm of circulating sclerostin in healthy young men
ea0032p72
Cross-correlation of circulating sclerostin over 24 h to PTH, phosphate and bone markers in healthy young men
ea0032p73
Bone quality, as measured by trabecular bone score (TBS), in patients with primary hyperparathyroidism
ea0032p74
Calcium homeostasis in women with non-metastatic breast cancer with osteoporosis after a single-dose of denosumab: a pilot study
ea0032p75
Long-term prospective evaluation of the effects of estroprogestagen therapy on the bone mineral density of girls with Turner syndrome carrying various PvuII AND XbaI polymorphisms of ER-[alpha]
ea0032p76
Cathepsin K secretion in human primary osteoblastic cell cultures and its influence by different glucose concentrations
ea0032p77
Effects of Denosumab treatment on insulin resistance in postmenopausal women with osteoporosis
ea0032p78
Impact of the FRAX[reg] tool and the NOGG guidelines on the indication of bone mineral density in Spanish postmenopausal women
ea0032p79
Increased IL17A serum levels associated with low estrogen levels can play a role in postmenopausal osteoporosis
ea0032p80
Effects of the tamoxifen on calcitonin producing thyroid C cells and bone in rat model of male osteoporosis
ea0032p81
The value of PRP/PRF in the treatment of bisphosphonates-induced maxillary osteonecrosis: preliminary study
ea0032p82
Bone mineral density in patients with hypersomatotropism
ea0032p83
Effects of treatment for acromegaly on bone mineral density: is pegvisomant protective on lumbar BMD?
ea0032p84
HLA class I, Cw*01 and Cw*15 alleles can play a preventing role in serum IL17 elevation associated with postmenopausal osteoporosis in Hungary
ea0032p85
Bone health in type 1 diabetes patients with celiac disease
ea0032p86
Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity
ea0032p87
Lean body mass and leptin, but not fat mass are independent predictors of bone mass in postmenopausal women
ea0032p88
Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women
ea0032p89
Vitamin D receptor polymorphisms and bone mass indices in post menarcheal indian adolescent girls
ea0032p90
Bone health in children with GH deficiency
ea0032p91
The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture
ea0032p92
Age overlooked as a risk factors for osteoporosis
ea0032p93
Trabecular bone score and bone mineral density in Ukrainian normal women depending on duration of postmenopausal period
ea0032p94
Bone metabolism with special emphasis to osteoprotegerin and vitamin D3 concentrations in premenopausal women with thyroid dysfunction
ea0032p95
Efficacy and safety of monthly oral minodronate for the treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients
ea0032p96
Change in bone mass in patients with established hyperthyroidism
ea0032p97
The follow-up in patients evaluated based on quantitative ultrasound: a prospective study
ea0032p98
Prospective study of bone mineral density in girls treated with estroprogestagens for functional hypothalamic amenorrhea during late puberty in relation to the polymorphism of VDR (BsmI), ER (PvuII; Xba I), and COLIA1 genes
ea0032p99
Vertebral fracture prevalence in postmenopausal women in relation to bone mineral density (BMD)
ea0032p100
Vertebral fractures in women with postmenopausal osteoporosis with or without prior fragile fracture
ea0032p101
Effect of long-term valproate therapy on bone health parameters
ea0032p102
Efficacy and safety of the anabolic therapies in severe osteoporosis: experience of a team of endocrinologists and spine surgeons
ea0032p103
Vitamin D receptor, BsmI, FokI, ApaI, TaqI and estrogen receptor alpha, PvuII and XbaI, gene polymorphisms in women with osteoporosis
ea0032p104
Possible benefits of PTH 1-84 therapy in pregnancy and lactation osteoporosis (PLO)
ea0032p105
Influence of some traditional risk factors for osteoporosis on bone metabolism during substitution therapy of primary hypothyroidism
ea0032p106
Resolution of anaemia after curative parathyroidectomy in a patient with primary hyperparathyroidism
ea0032p107
A case of 23 years old woman with primary hyperparathyroidism presenting with pathological fracture and brown tumors detected by scintigraphy
ea0032p108
A patient osteogenesis imperfecta with osteoporosis
ea0032p109
Fear of illness and quality of life in Greek postmenopausal women with osteoporosis
ea0032p110
Calcium and Vitamin D metabolism
The relationship between low maternal serum 25-hydroxyvitamin D level and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency
ea0032p111
Effects of vitamin D fortified bread on muscle strength
ea0032p112
Evaluation of two routinely used 25OHD assays and serum variables in patients on dialyses
ea0032p113
Vitamin D supply in healthy women with different reproductive stages: is there any relationship with DBP levels?
ea0032p114
Cinacalcet in patients with primary hyperparathyroidism (PHPT): comparison between sporadic and MEN1 PHPT
ea0032p115
Efficacy of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled clinical trial
ea0032p116
Lower CD4 lymphocyte counts in HIV/HCV co-infected patients with liver fibrosis on long term HAART and low vitamin D level
ea0032p117
Replenishment of reduced vitamin D levels: how much vitamin D is necessary?
ea0032p118
Changes in anxiety and depression symptoms in patients with chronic fatigue syndrome treated with vitamin D
ea0032p119
The effects of vitamin D therapy on thyroid functions, thyroid autoantibodies, TNF-[alpha];, IL6 and IL1b in patients with autoimmune thyroiditis
ea0032p120
Genetic analysis of AIP genes in familial primary hyperparathyroidism
ea0032p121
A986S or the R990G polymorphism in CASR does not explain hypercalciuria and low normal serum calcium
ea0032p122
Early measure of postoperative iPTH and corrected calcium as predictors of future hypoparathyroidism: which, when and why?
ea0032p123
Serum sclerostin and Dkk1 in patients with parathyroid disorders
ea0032p124
An observational study reveals that neonatal vitamin D is primarily determined by maternal contributions: implications of a new assay on the roles of vitamin D forms
ea0032p125
Vitamin D and sarcopenia in HIV-infected patients
ea0032p126
Lithium-associated hyperparathyroidism: a case report
ea0032p127
Late-onset hypoparathyroidism 15 years after thyroidectomy
ea0032p128
Does recognition of vitamin D deficiency affect the indication for surgical treatment in asymptomatic primary hyperparathyroidism?
ea0032p129
Fahr's disease with dystonia: a case report
ea0032p130
Predictive factors of postoperative hypoparathyroidism after total thyroidectomy
ea0032p131
Normocalcemic primary hyperparathyroidism: an Italian epidemiologic study
ea0032p132
Plasma lipid levels in relation to the status of vitamin D sufficiency
ea0032p133
Primary hyperparathyroidism and vitamin D deficiency. therapeutic implications
ea0032p134
Prevalence and correlates of vitamin D deficiency in Turkish adults
ea0032p135
Vitamin D deficiency in urban adult population of south-eastern Poland
ea0032p136
The effects of lactose intolerance and lactose intolerance associated diseases on serum vitamin D levels, bone metabolism markers, bone mineral density and bone fractures
ea0032p137
Normocalcemic hyperparathyroidism
ea0032p138
Familiar hypocalciuric hypercalcemia a rare cause of hypercalcemia
ea0032p139
Vitamin D deficiency in lithuanian school graduates females
ea0032p140
Does vitamin D status predict handgrip strength in young adult women?
ea0032p141
Influence of preoperative characteristics in the result of Tc99m-sestaMIBI scan in patients with primary hyperparathyroidism
ea0032p142
Cystic parathyroid adenomas: ultrasonography features
ea0032p143
Primary hypoparathyroidism and autoimmune endocrine disorders
ea0032p144
Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment
ea0032p145
Primary hyperparathyroidism in people under 30
ea0032p146
An extensive precipitation of calcium in subcutaneous tissue in patient with juvenile dermatomyositis
ea0032p147
Measurement of 25-hydroxyvitamin D: evaluation of the new DIAsource ELISA assay
ea0032p148
Persistent primary hyperparathyreoidism
ea0032p149
Prevalence of multiple endocrine neoplasia type 1 syndrome in primary hyperparathyroidism
ea0032p150
Does the severity of vitamin D deficiency affect the prevelance of gastrointestinal polyps?
ea0032p151
Vitamin D deficit and metabolic syndrome
ea0032p152
Vitamin D deficiency predicts incidence of obesity
ea0032p153
Vitamin D deficiency in morbid obesity before and after bariatric surgery
ea0032p154
The association of low serum 25-hydroxyvitamin D and serum osteocalcin levels with the metabolic syndrome in females with polycystic ovary syndrome in Al-Baha region, Saudia Arabia: a case-control study
ea0032p155
MSIA--SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples
ea0032p156
Vitamin D deficiency, secondary hyperparathyroidism and it's influence on bone mineral density
ea0032p157
Comparative study of bone metabolic parameters and vitamin D levels of fertile aged women, suffering from different bone metabolism altering diseases
ea0032p158
Structure and frequency of clinical manifestations of primary hyperparathyroidism
ea0032p159
A case report: hypoparathyroidism, nephrocalcinosis, and replacement therapy
ea0032p160
Abstract unavailable
ea0032p161
The prognostic value of peripheral neuropathy for the mortality and its relation to secondary hyperparathyreoidism: a 10-month follow up of 97 patients with end-stage renal disease
ea0032p162
Postsurgical hypoparathyroidism with 'normal' PTH
ea0032p163
Evaluation of concentration 25OH vitamin D 3 selected patient population: preliminary report
ea0032p164
Evaluation of concentration 25OH vitamin D 3 in the population over 65 years old: preliminary report
ea0032p165
Cardio-metabolic risk factors in subjects with Vit D deficiency
ea0032p166
Hyperparthyroidism: are male forms more or less aggressive?
ea0032p167
A clinical case of complicated hyperparathyroidismwith diagnosis delay due to vitamin D deficiency
ea0032p168
Impact of vitamin deficiency and oF GH-IGF1 on cardiovascular risk in hypopituitaric patients
ea0032p169
Primary hyperparathyroidism in patients with urolithiasis: prevalence and predictors
ea0032p170
Could PHPT be diagnosed at early stages even more frequently?
ea0032p171
Relation between carotid intima media thickness and vitamin D in hypertension
ea0032p171.1
Cardiovascular Endocrinology & Lipid Metabolism
Lipid levels in acromegaly
ea0032p172
Testosterone stimulates cholesterol metabolism and efflux from human macrophages via liver X receptor
ea0032p173
Testosterone differentially regulates liver X receptor expression and targets of lipid and glucose metabolism in liver, muscle and adipose tissue of the testicular feminised mouse
ea0032p174
Oxytocin, a new regulator of cardiomyocyte hypertrophy
ea0032p175
Long QT interval in Turner syndrome: a high prevalence of LQTS gene mutations
ea0032p176
Osteoprotegerin and RANKL levels in instable coronary artery disease
ea0032p177
Intestinal cholesterol-transport gene expression is associated with abnormalities in post-prandial endothelial function and carotid intima-media thickness independent of insulin resistance
ea0032p178
Mediterranean diet modulates the effect of rs1761667 in the CD36 gene on FFA concentration and BMI in a high cardiovascular risk population
ea0032p179
The effect of aerobic exercise on ectopic lipids intramyocellular, intrahepatocellular, and intracardiomyocellular lipids in physically active, healthy individuals
ea0032p180
Can hypothyroidism manifest as ischemic heart disease in elderly patients with the absence of significant coronary atherosclerosis?
ea0032p181
Short-term changes in serum sex steroid levels and cardiac function in healthy young men
ea0032p182
Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality
ea0032p183
Adults with GH deficiency have subclinical longitudinal left ventricular dysfunction, without significant vascular function impairment, suggesting intrinsic myocardial disease
ea0032p184
Mechanism of oxytocin-mediated cardiomyocyte protection
ea0032p185
The effect of testosterone replacement on endothelial dysfunction, inflammation and insulin resistance in male hypogonadotrophic hypogonadism
ea0032p186
TSH and arterial stiffness in healthy postmenopausal women
ea0032p187
A potential predict value of circulating osteoprotegerin in diabetic patients with asymptomatic coronary artery disease
ea0032p188
Metabolic profile of transsexual persons on cross-sex hormonal therapy in a multi-center prospective intervention study
ea0032p189
Changes in lipid profile and markers of metabolic syndrome after 3 years of testosterone-therapy in female-to-male transsexuals
ea0032p190
Pentraxin-3 as a more sensitive marker of coronary artery disease severity than C-reactive protein
ea0032p191
Effect of cross-sex hormone treatment on lipid profile in transsexual individuals: experience in a specialized unit in Catalonia
ea0032p192
HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism
ea0032p193
The activity of inflammation and the blood redox status in patients with coronary heart disease and type 2 diabetes mellitus
ea0032p194
Utility of N-terminal pro-brain natriuretic peptide in the evaluation of patients with high clinical probability of non-ST segment elevation acute coronary syndrome
ea0032p195
Perturbed sympatho-vagal balance in Turner syndrome: relation to phenotype and aortic dilation
ea0032p196
Impact of subclinical thyroid dysfunction on mortality among patients presenting with cardiovascular events
ea0032p197
Abstract unavailable
ea0032p198
Lipid levels in patients with rheumatoid arthritis and the effect of rituximab
ea0032p199
Linear growth and IGF1 concentrations in children cyanotic and acyanotic congenital heart disease before vs after intervention
ea0032p200
Changes of expression of regulators of calcification in different stages of atherosclerosis in vasculature and bone
ea0032p201
Dyslipidemia associated with m-TOR inhibitors treatment
ea0032p202
Rising prevalence of fatty liver in India and its correlates
ea0032p203
CNR1 polymorphisms and metabolic disorders in woman with PCOS-preliminary report
ea0032p204
Oleic vs linoleic effects on hepatic sex hormone-binding globulin production
ea0032p205
Post prandial responses in insulin, free fatty acid and endothelial function following to Malaysian vs Mediterranean meals among healthy subjects
ea0032p206
Subclinical atherosclerosis and cardiovascular risk in healthy, young menopausal women
ea0032p207
Comparative effects of atorvastatin and rosuvastatin on vitamin D levels, glucose metabolism and systematic inflammation in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study
ea0032p208
Clinical experience with exenatide and liraglutide in the internal medicine service two of hospitals in Valencia
ea0032p209
Effect of one session resistance exercise on C-reactive protein and cardio metabolic risk factors in trained and untrained healthy students
ea0032p210
Combination therapy in diabetic patients with insulin glargine and exenatide in the internal medicine service two of hospitals in Valencia
ea0032p211
Metabolic disorders in a group of Algerian hypersomatotropic subjects
ea0032p212
Clinical case reports – Pituitary/Adrenal
Case report: chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue
ea0032p213
An unusual case of Cowden-like syndrome, neck paraganglioma and pituitary adenoma
ea0032p214
Follicle-stimulating hormone-secreting pituitary macroadenoma: a rare cause of abnormal menstrual cycles in a teenage girl
ea0032p215
Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression
ea0032p216
Histologically surprising nasal polyps
ea0032p217
Hypopituitarism and pituitary masses in patients with non-pituitary malignancy
ea0032p218
Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood
ea0032p219
Adequate timing for adrenalectomy in pheochromocytoma multisystem crisis: can early biochemical diagnosis be the key?
ea0032p220
Complex hypothalamic disorder after childhood histiocytosis X
ea0032p221
Morphologial and functional abnormalities of the hypofyse in patients with diagnose of CFS or fibromyalgia. An example of misdiagnosis by Belgian chronic fatigue centres
ea0032p222
Pineal gland tumor and panhypopituitarism in an adult male
ea0032p223
Antepartum pituitary insufficiency in type 1 diabetes
ea0032p224
Delivery of health child in acromegaly patient with McCune-Albright syndrome treated with lanreotide and pegvisomant during pregnancy
ea0032p225
Intrasellar plasmacytoma: an unusual presentation of multiple myeloma
ea0032p226
Corticomedullary mixed adrenal tumor
ea0032p227
Xanthomatous hypophysitis as a cause of cluster headache: a case report
ea0032p228
Primary adrenal insufficiency in a case of bilateral adrenal hemorrhage secondary to anti-phospholipid syndrome masquerading as chronic abdominal pain
ea0032p229
Very late growth acceleration in a man with hypopituitarism
ea0032p230
Differential diagnosis of aggresive macroprolactinoma, adenoma or atypical adenoma: a case report
ea0032p231
Bilateral third nerve palsy secondary to an apoplexy in a pituitary macroadenoma causing Cushing's disease: a very rare complication of a rare entity
ea0032p232
Good response to temozolamide therapy in a man with a prolactin secreting pituitary carcinoma
ea0032p233
Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene
ea0032p234
Acute pulmonary edema as the initial presentation of a pheochromocytoma: case report
ea0032p235
Pleuropericarditis effusion secondary to chronic bromocriptine intake
ea0032p236
Suppurative meningitis as a life threatening primary presentation of macroprolactinomas
ea0032p237
Craniofacial fibrous dysplasia and pituitary gigantism in a 10-year-old boy: clinical case
ea0032p238
Functional and transient effect of sodium excretion in combined pituitary failure with central and peripheric diabetes insipidus
ea0032p239
Management of resistant prolactinoma: case report
ea0032p240
Addisonian crisis: rapid correction of hyponatriemia leads to osmotic myelinolysis
ea0032p241
Pituitary apoplexy after suppression test in a patient with Cushing's disease due to macroadenoma
ea0032p242
Osteoporotic fractures as manifestation of Cushing's disease
ea0032p243
Cerebrospinal meningitis in 30-year-old man as first manifestation of pituitary macroadenoma
ea0032p244
Ectopic acth dependent Cushing syndrome diagnosed with octreotide scan
ea0032p245
Thalassemia minor associated with multiple pituitary hormone deficiency
ea0032p246
Occurrence of De Quervain's thyroiditis after resolution of hypercortisolism following SOM230 treatment for Cushing's disease and surgery for an adrenocortical adenoma: report of two cases
ea0032p247
Nephrogenic systemic fibrosis: potential aetiology of pituitary stalk thickening post- commencement of dialysis: case report
ea0032p248
Extraadrenal paraganglioma: case report
ea0032p249
Newly discovered adrenal tumor and pituitary microadenoma in a patient known with classical congenital adrenal hyperplasia
ea0032p250
Malignant schwannoma in a patient with hypopituitarism, congenital hydrocephalus, atrial septal defect and agenesis of right kidney
ea0032p251
Non-Hodgkin's lymphoma presenting as anterior hypopituitarism
ea0032p252
A case of ACTH producing oat cell carcinoma cause of ectopic Cushing's syndrome and life threatening hypokalaemia
ea0032p253
Recurrent pituitary tumor: the importance of a functional classification at diagnosis
ea0032p254
Congenital trans-sphenoidal meningocele: an uncommon cause of pituitary insufficiency
ea0032p255
Isolated ACTH deficiency with Brugada syndrome: a combination increasing the risk of fatal arrhythmia
ea0032p256
A case of primary adrenal failure diagnosed in postpartum period
ea0032p257
TSH secreting pituitary adenoma: a case report
ea0032p258
Gastrointestinal bleeding associated with Dabigatran in a patient with panhypopituitarism
ea0032p259
Therapeutic dilemmas in a young male patient with macroprolactinoma complicated by hypogonadism
ea0032p260
Baraitser Winter's syndrome and GH deficiency
ea0032p261
Beer potomania masquerading as adrenal insufficiency
ea0032p262
Isolated ACTH deficiency associated with Hashimoto's disease
ea0032p263
Cases with adrenocortical carcinoma
ea0032p264
Differential diagnosis of an incidental pituitary lesion detected with PET-CT in a patient with a known history of metastatic maxillary sinus tumor
ea0032p265
Secondary hypertension and hirsutism as a clinical manifestation of the tumor duplicity: case report
ea0032p266
Treatment dilemmas of Cushing disease: case report
ea0032p267
Adrenocortical carcinoma: a case report
ea0032p268
Fountain of steroid deep within: a case report of an ectopic ACTH-producing tumor
ea0032p269
Clinical case reports - Thyroid / Others
Low TSH plasma levels and high fracture risk in postmenopausal osteoporosis and osteopenia patients
ea0032p270
Malignancy rate of thyroid nodules, which defined as follicular lesion of undetermined significance and atypia of undetermined significance in thyroid cytopathology and relation with ultrasonographic features
ea0032p271
Recurrent pregnancy induced hypercalcaemia resulting in multiple terminations of pregnancy
ea0032p272
Familial Graves' disease: case report
ea0032p273
Paraganglioma, germline nonsense mutation in succinate dehydrogenase B gene (R27X) and response to sunitinib
ea0032p274
Submandibular ectopic thyroid gland
ea0032p275
Barraquer-Simons syndrome
ea0032p276
Dural ectasia accompanying a case of multiple endocrine neoplasia type 2B
ea0032p277
Coexistence of euthyroid ophthalmopathy and isolated ocular myasthenia gravis in a patient with vitiligo: a challenging diagnosis of APS-3C
ea0032p278
Giant cell granuloma as initial presentation of primary hyperparathyroidism: a case report
ea0032p279
Fibrous variant of Hashimoto's thyroiditis: development of neck fibrosis and mediastinal fibrosis
ea0032p280
Differentiated thyroid cancer presenting as chylothorax
ea0032p281
A case of confirmed Smith-Lemli-Opitz syndrome
ea0032p282
A case of generalized resistance to thyroid hormone with chronic thyroiditis
ea0032p283
Autoimmune hypothyroidism converted to hyperthyroidism: is it a common phenomenon?
ea0032p284
Maturity onset diabetes of youth (MODY) in a patient with VATER syndrome
ea0032p285
Plasmapheresis in rapid preparation of a patient with toxic multinodular goiter for surgery
ea0032p286
Postmenopausal hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary
ea0032p287
Clinical case report: male patient with SRY-positive 46,XX testicular disorder of sex development
ea0032p288
Insulin autoimmune syndrome, IAS (Hirata disease) case report
ea0032p289
Neurogenic hypertension as a case report
ea0032p290
Immobilisation hypercalcaemia in a young man
ea0032p291
Parathyroid carcinoma: an atypical case in a patient submitted to Bariatric surgery
ea0032p292
Autoimmune polyglandular syndrome type IV with twins pregnancy: clinical, diagnostic, evolutive aspects and treatment
ea0032p293
Hypercalcemia in patient five years after the diagnosis of gastrinoma
ea0032p294
Presence of Paget's disease in a patient with endometrium carcinoma
ea0032p295
Parathyroid carcinoma
ea0032p296
Primary hyperparathyroidism associated with atrial septal defect, interatrial septal aneurisym and skeletal anomaly: a case report
ea0032p297
Hypercalciuria in a patient with central diabetes insipidus
ea0032p298
A recurrent case of subacute thyroiditis improved with the onset of pregnancy
ea0032p299
High rate of malignant disorders in patients with primary hyperparathyroidism
ea0032p300
Experience in the use of Tolvaptan in elderly patients with significant hyponatraemia
ea0032p301
Hypercalcemia secondary to concomitant thyrotoxicosis and B cell lymphoma
ea0032p302
Hyperthyroidism-induced heart block: a case series in the Philippine general hospital
ea0032p303
A case with thyroid acropachy as the initial manifestation of thyrotoxicosis
ea0032p304
Postmenopausal Sertoli-Leydig cell tumor in two patients
ea0032p305
Adefovir diproxivil-induced acquired Fanconi's syndrome presenting as hypokalemia
ea0032p306
Prolonged ventilator dependence in myxedema coma: a case report and review of the literature
ea0032p307
Graves' disease associated with severe hypoalbuminemi
ea0032p308
Graves' disease associated with Alopecia areata developed after Hashimoto's thyroiditis
ea0032p309
Challenges in the management of hypogonadotropic hypogonadism
ea0032p310
Abstract removed
ea0032p311
Report of a case of hyperandrogenism in a postmenopausal woman
ea0032p312
Primary octreotide therapy in a patient with pituitary adenoma cosecreting GH and TSH
ea0032p313
Follicular thyroid cancer with functioning lung metastasis
ea0032p314
Wegener's granulomatosis in a patient with vitamin D deficiency
ea0032p315
Mixed medullary-follicular carsinoma of the thyroid: two case reports
ea0032p316
Cyclosporine induced autoimmune thyroid disease: presentation of two cases
ea0032p317
Never too late to discover some extra thyroid tissue
ea0032p318
Everolimus. a new therapeutic target in the metastatic neuroendocrine carcinoma
ea0032p319
Torsade de pointes caused by gluten sensitive enteropathy leading to multiplex endocrine failure: case report
ea0032p320
Atypical parathyroid adenoma presenting with severe hypercalcemia: a case report
ea0032p321
Severe hyponatraemia in patients admitted to acute medical unit
ea0032p322
Androgen abuse complicated by polycythemia in a man with acquired immunodeficiency syndrome (AIDS)
ea0032p323
Abstract unavailable
ea0032p324
A rare presentation of DRESS-associated thyrotoxicosis and myocarditis: case report
ea0032p325
Radiation-induced primary hypothyroidism in patients with head and neck cancer
ea0032p326
A case of type 1 diabetes represented by diabetic ketoacidosis after isotretinoin therapy: is it a result or coincidence?
ea0032p327
Lithium-associated hyperparathyroidism: a case report
ea0032p328
Thyrotoxic periodic paralysis in young Caucasian
ea0032p329
Persimonious indications for thyroidectomy in chronic thyroiditis
ea0032p330
The coexistence of vaginismus with arthritis after pharmacological treatment of hyperthyroidism: is it only a coincidence?
ea0032p331
Developmental Endocrinology
Crystal structure of the complex between an insulin-like peptide (DILP5) and an ILP binding protein (IMP-L2) from Drosophila melanogaster
ea0032p332
Changes in sexual orientation in gender identity disorder: evaluation of their association to sex reassignment surgery and cross-sex hormone treatment
ea0032p333
Somatostatin receptor sst2 transfer in somatolactotroph cell line. Constitutive activity and drug sensitivity
ea0032p334
The distinctive roles of thyroid hormone receptors in the development of zebrafish tissues
ea0032p335
Effects of pharmacological and genetic manipulation of glucocorticoids during early development of the zebrafish embryo
ea0032p336
A study on the relationship between energy reserves and energy expenditure during the time of male puberty
ea0032p337
TurboFlow-LC-MS/MS method for quantification of DHEA, DHEAS, 17[alpha]-hydroxyprogesterone, [delta]-androstenedione and testosterone in children
ea0032p338
The prevalence, incidence and diagnostic delay in 46,XY females; a Danish national cohort study
ea0032p339
Effects of prenatal antiandrogen exposure on HSD3B expression in the fetal porcine gonads
ea0032p340
Characteristics of the HIV positive transgender population of Catalonia
ea0032p341
Optimising strategies for face classification in the detection of acromegaly
ea0032p342
Evaluation of adults with phenyketonuria from pediatric to adult care
ea0032p343
Resistant hypertension: about 30 cases
ea0032p344
High blood pressure in young adults: 84 cases
ea0032p345
Diabetes
Elevation of circulating free fatty acids abolishes down-regulation of skeletal muscle adiponectin receptor 1 (AdipoR1) expression caused by insulin infusion
ea0032p346
Short stature, low-set ears, short 5.finger, undescended testis, bradycardia
ea0032p347
Long-acting insulin analogs exposure and cancer specific mortality in patients with diabetes mellitus
ea0032p348
Expression of adiponectin gene and adiponectin receptors in placental and adipose tissue in women with gestational diabetes mellitus
ea0032p349
Effects of Vaspin on expressions of NF-[k]B and its target genes in endothelial EA.hy926 cells
ea0032p350
Skeletal muscle and adipose tissue glycoprotein 130 expression is associated with insulin resistance in humans
ea0032p351
Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study
ea0032p352
Autoantibodies to the insulin- and IGF1-receptor in human sera
ea0032p353
Physiological role for Angptl4/fiaf in exercise-induced muscle AMPK activation
ea0032p354
Predictive value of HbA1c and glucose fluctuations in hypoglycemia risk in patients with type 1 diabetes
ea0032p355
Risk factors for impaired glucose tolerance and diabetes mellitus after liver transplantation
ea0032p356
Acute exercise leads to increased HbA1c and fructosamine levels in athletes with type 1 diabetes
ea0032p357
Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study
ea0032p358
Reconsidering guidance for postnatal glucose screening in gestational diabetes
ea0032p359
TCF7L2 gene polymorphisms may influence insulin sensitivity and leptin levels independently from BMI and body fat content
ea0032p360
Type 2 diabetes and prostate cancer risk in Korean men with low PSA
ea0032p361
The association between severity of impaired glucose tolerance in gestational diabetes with age, BMI, and ethnicity in the UK
ea0032p362
High prevalence of elevated liver transaminases among 38 727 patients in a diabetes centre in the United Arab Emirates
ea0032p363
Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet
ea0032p364
Prediabetes in human immunodeficiency virus-infected patients: prevalence and clinical significance
ea0032p365
Clinical experience of a monogenic diabetes unit during 2008-2012 in the Department of Endocrinology and Nutrition (Malaga, Spain)
ea0032p366
Progression to impaired glucose metabolism in normal glucose tolerant urban population
ea0032p367
Impact of the insulin pump therapy on quality of life children and adolescents with diabetes mellitus type 1
ea0032p368
Relation of serum chemerin level with markers of atherosclerosis in diabetes and prediabetes
ea0032p369
Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum
ea0032p370
Abstract unavailable
ea0032p371
Association between toll-like receptor 4 polymorphism and type 2 diabetes mellitus
ea0032p372
Altered reactivity of pituitary-adrenal axis to stimulation tests and altered tissue metabolism of cortisol in long-standing type 1 Diabetes
ea0032p373
The effects of gestational diabetes on basal metabolic rate in pregnancy
ea0032p374
Gene expression of TLR2, TLR4, and TLR9 in human PBMCs with diabetes
ea0032p375
Prevalence of achievement of HbA1c, blood pressure, and cholesterol (ABC) Goal in Koreans with diabetes
ea0032p376
Nutritional status assessment in patients with cystic fibrosis
ea0032p377
The expression mechanism of lipocalin-2 by co-stimulation with interleukin 1[beta]; and interferon [gamma]; in RINm5F [beta];-cells
ea0032p378
The effect of CCR2 G190A gene polymorphism on development of diabetic coronary artery disese
ea0032p379
High prevalence of the metabolic syndrome among newly diagnosed type 2 diabetes patients in Denmark
ea0032p380
Trans-operative and post-operative medical complications in patients with diabetes mellitus type 2
ea0032p381
Assessment of pre-pregnancy BMI in patients with gestational diabetes
ea0032p382
Study of the development and validation of the specific [
ea0032p383
Inflammatory markers in diabetic foot and impact of vitamin D deficiency
ea0032p384
Study of the prevalence of subclinical hypothyroidism in type 2 diabetic Egyptian women
ea0032p385
Maternal serum fetuin-A, leptin, and hs-CRP concentrations in gestational diabetes
ea0032p386
The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus
ea0032p387
Identification of plasma biomarkers in human diabetic retinopathy
ea0032p388
Diabetes awareness in the general population of northern Greece
ea0032p389
Insulin resistance among adults with type 1 diabetes mellitus
ea0032p390
Atypical early onset Werner's syndrome
ea0032p391
Potentialities of skin impedance spectroscopy in vivo in non-invasive monitoring of glucose level
ea0032p392
Association of plasma testosterone concentration with cardiovascular risk factors in young Chinese men of type 2 diabetes mellitus
ea0032p393
Leptin and other adipocins in patients with type 2 diabetes
ea0032p394
Leptin, resistin and omentin in patients with the obesity and with impaired glucose tolerance
ea0032p395
Quality of care in diabetic patients
ea0032p396
Lipid profile of patients newly diagnosed with type 2 diabetes in Albania
ea0032p397
Glycemic and lipid profile in patients with acute pancreatitis
ea0032p398
Practical knowledge about diabetes and the risk of death: 9-year observation
ea0032p399
Blood pressure control in type 2 diabetic patients with overweight or obesity in Guangdong Province: a cross-sectional survey
ea0032p400
The role of a lifestyle modification in preventing type 2 diabetes mellitus and influence it on changes serum leptin levels
ea0032p401
Signs of accelerated carotid atherosclerosis assessed by MRI in newly diagnosed type 2 diabetes
ea0032p402
Cardiovascular risk management in the patients with type 2 diabetes mellitus
ea0032p403
Circulating endothelial progenitor cells as a predictor of clinical outcomes in diabetic patients with symptomatic chronic heart failure
ea0032p404
Correlations between umbilical and maternal adiponectin as well as neonatal birthweight
ea0032p405
The relationship between glycemic control and BNP levels in diabetic patients
ea0032p406
Diagnostic and prognostic value of system matrix mettalloproteinases-1 in patients with diabetes mellitus 2 type
ea0032p407
Fibroblast growth factor 21: a new predictor of cardiovascular events in type 2 diabetes
ea0032p408
Diabetes and hyperglycemia: relation with clinical outcome in the community acquired pneumonia
ea0032p409
iNOS, eNOS, and XOR involvement in hyperglycaemia-induced kidney injury in rats with streptozotocin diabetes mellitus
ea0032p410
Advanced glycation end-products inhibit insulin signaling in human granulosa cells
ea0032p411
Diabetic polyneuropathy course clinical features of patients with various age of diabetes demonstration
ea0032p412
Cardiovascular risk and prevalence of metabolic syndrome in LADA patients depending on thyroid autoimmunity presence
ea0032p413
Endothelial dysfunction in type 2 diabetic patients; its relation with level of albuminuria and frequency of the microvascular complications
ea0032p414
Association between type 1 diabetes and oral health status
ea0032p415
Lower incidence of severe hypoglycaemia during pregnancy in a recent cohort of women with type 1 diabetes followed in a routine care setting
ea0032p416
Association between periodontal disease and vitamin D status in a type 1 diabetic population
ea0032p417
The role of cardio metabolic markers to predict carotid intima media thickness in type 2 diabetic patients
ea0032p418
Improvement in sympathetic cardiac autonomic functions after 6 months of comprehensive yogic breathing program in patients with diabetes
ea0032p419
Relationship between metformin treatment and hyperlactacidemia diagnosed at the emergency room
ea0032p420
Type 1 diabetes and pregnancy: importance of glycemic control in maternal and perinatal outcomes
ea0032p421
Assessment of glycemic control in patients with T1DM and depression
ea0032p422
The peculiarities of atherosclerotic coronary arteries lesion in patients with coronary artery disease and type 2 diabetes mellitus
ea0032p423
The influence of resistin on liver function in patients with diabetes mellitus type 2 and obesity
ea0032p424
Risk factors and outcomes of periferal artery disease in patients with diabetes mellitus
ea0032p425
Early on evaluation of hearing function with transient evoked otoacoustic emissions (TEOAE) and distortion product otoacoustic emissions (DPOAE) in type 2 diabetic patients without hypertension
ea0032p426
Maternal 75 g OGTT glucose levels as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus
ea0032p427
The influence of erythropoietin therapy on renal function and proteinuria level in patients with early diabetic nephropathy
ea0032p428
The diabetic hand: a forgotten complication?
ea0032p429
Echocardiographic parameters and blood pressure in normoalbuminuric prehypertensive diabetic patients
ea0032p430
Relationship between endothelin-1 levels in diabetics with and without microangiopathy and control subjects
ea0032p431
Diabetic polyneuropathy predictors
ea0032p432
Endothelial dysfunction in diabetes mellitus
ea0032p433
Risk factors and diabetic foot wound classification: ten years of follow-up
ea0032p434
Smoking and progression of diabetic nephropathy in type 1 diabetes mellitus
ea0032p435
Association of C-reactive protein and nephropathy in type 1 diabetic patients
ea0032p436
Relation of high sensitive CRP and insulin resistance to retinopathy in type 2 diabetes
ea0032p437
Assessment of hypoglycemia risk factors in insulin treated patients
ea0032p438
Admissions of diabetic patients due to hypoglycemia of external cause in a central hospital from 2006 to 2012
ea0032p439
Ambulatory blood pressure profiles in type 2 diabetic patients
ea0032p440
Studying the effect of hypertriglyceridemia and hyperglycemia on the outcome of pregnancy in diabetics and nondiabetics
ea0032p441
Severe diabetic ketoacidosis in type 2 diabetes mellitus
ea0032p442
Disabilities of the arm, shoulder and hand (DASH) questionnaire and diabetic complications: preliminary results
ea0032p443
Impact of a comprehensive management of glycemic profile, arterial hypertension and dislypidemia on the onset of type 2 diabetes mellitus
ea0032p444
Monoballism associated with newly onset ketotic Hyperglycemia
ea0032p445
Comparison of Irbesartan and combination with Nigella sativa oil in experimental diabetic nephropathy
ea0032p446
Association lipids with albuminuria in patients with type 1 diabetes
ea0032p447
Characteristics of the patients treated at the onset of type 2 diabetes mellitus in our Diabetes Day Hospital (DDH) during 2010-2011
ea0032p448
Lipid profile in type 1 diabetic patients in Kragujevac
ea0032p449
Association of type II diabetes mellitus with hepatocelular carcinoma occurrence. A case control study from Western Nepal
ea0032p450
HbA1c levels did not correlate with SF-36 and DQOL scores in patients with poorly controlled type 2 diabetes
ea0032p451
Diabetic ketoacidosis in hospitalized patients with hypertriglyceridemia induced pancreatitis. Case control study
ea0032p452
Deficiency of vitamin D3 in patients with diabetic retinopathy
ea0032p453
A poorly controlled type 2 diabetes complicated by an episode of severe hypertriglyceridemia-induced pancreatitis
ea0032p454
Self care practice among diabetic patients in Kathmandu
ea0032p455
Newly diagnosed diabetic patient presenting with crural infection
ea0032p456
Relation between psychiatric symptoms and diabetic complications: preliminary results
ea0032p457
Pelvic pain in a type 2 diabetes patient
ea0032p458
Marking out group of the increased risk of disorder of the mineralization of the osseous tissue at patients with diabetes
ea0032p459
Postprandial hypotension is attenuable with Acarbose treatment in older adults with diabetes mellitus type 2: a randomized controlled crossover cohort study
ea0032p460
Effect of bariatric surgery on serum glucagon like peptide-1 concentration and metabolic parameters among obese type 2 diabetics
ea0032p461
Ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes
ea0032p462
Clinical usefulness of a bolus calculator in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion (CSII)
ea0032p463
Effects of human insulin and insulin aspart preparations on levels of IGFI, IGFBPs and IGFI bioactivity in patients with type 1 diabetes
ea0032p464
Vitamin B12 deficiency in type 2 diabetic patients on metformin
ea0032p465
Medical staff experience and acceptance of an ICU insulin infusion protocol in a tertiary hospital in the Philippines
ea0032p466
Efficacy and safety of 1 year treatment with Liraglutide in subjects with type 2 diabetes
ea0032p467
Metabolic surgery assessment score (MSAS): a tool to predict diabetes remission after modified bariatric surgery
ea0032p468
No benefit for mortality but advanced risk of hypoglycemia with intensive glucose control in critical care unit brain injured patients: a meta-analysis of RCTs
ea0032p469
Monitoring and control of blood glucose levels in patients with inefficiently controlled insulin-treated diabetes mellitus through the utilization of an on-line telemonitoring system
ea0032p470
Insulin detemir has similar effect when using single daily dose with same dose twice daily as basal insulin therapy with oral antidiabetics.
ea0032p471
Factors related to nonadherence with diabetes treatment among Brazilian type 2 diabetes mellitus patients
ea0032p472
Cardiovascular effects of treatment with Liraglutide in a population with type 2 diabetes
ea0032p473
Therapeutic swicht at discharge improves medium term metabolic control in patients with type 2 diabetes and high vascular risk
ea0032p474
Abstract unavailable
ea0032p475
Impact on weight and glycemic control in patients with type 2 diabetes and obesity treated with liraglutide
ea0032p476
Short-term, temporary insulin degludec, an ultra-long-acting basal insulin, as compared with glargine on the glycemic control in Japanese patients with type 2 diabetes
ea0032p477
Perioperative liraglutide therapy for orthopedic patients with T2DM
ea0032p478
Insulinator: a computer program to help in the insulin therapy
ea0032p479
The long term effect of metformin plus DPP-4 inhibitor switching from metformin plus pioglitazone combination therapy in type 2 diabetes
ea0032p480
Protective effects of Swietenia macrophylla King (seed [amp] endocarp) aqueous-methanolic extract on pancreatic islet histology in streptozotocin-induced diabetic rats
ea0032p481
Are there gender differences in liraglutide response in adults with type 2 diabetes?
ea0032p482
Degree of glycemic control in treated type 2 diabetic patients who live in a district of Madrid, Spain
ea0032p483
Copeptin: may it be a novel biomarker for insulin theraphy in subjects with diabetes?
ea0032p484
Efficacy and safety of liraglutide in morbid obese patients in first year of commercialization in Spain
ea0032p485
Evaluation of adolescents with type 1 diabetes after transition from paediatric to adult care
ea0032p486
Insulin pump therapy as an obligatory treatment modality in a type 2 diabetic patient
ea0032p487
Absence od metformin therapy and inadequate insulin doses are the basic features of diabetic patients with unregulated diabetes
ea0032p488
Analysis of the newly diagnosed diabetic patients, one year and five years of evolution, C-peptide, autoinmunity, treatment and metabolic control
ea0032p489
Assesment of diabetes knowledge evaluation in type 2 diabetic patients
ea0032p490
Advantages of using DPP-4 inhibitors in patients with type 2 diabetes mellitus and overweight
ea0032p491
Hypoglycemic evaluation of Swietenia macrophylla King combined seed and endocarp extracts: a comparative study between hot water extraction and aqueous-methanol extraction
ea0032p492
Evaluation of BICI therapy in pregestational type 1 diabetes
ea0032p493
Quality indicator of glycemic status in patients with diabetes mellitus in primary health care in the Kyrgyz Republic
ea0032p494
Pre-diabetes study in Libya: delay and prevention T2DM
ea0032p495
Molecular docking research analysis of novel natural and synthetic PTP 1B inhibitors as potential therapeutic target for diabetes mellitus
ea0032p496
Endocrine disruptors
Reproductive aging in rats is altered by developmental exposure to mixtures of endocrine disrupters
ea0032p497
An investigation about metabolic disruption: organostannic compounds as PPAR gamma agonists
ea0032p498
Tributyltin changes the thyroid gland morphology of male rats
ea0032p499
Sex hormone-induced gender differences in vascular muscle cells motility are susceptible to the environmental disruptors
ea0032p500
Vitamin E protects against methomyl-induced reproductive toxicity in pregnant female rats
ea0032p501
Bisphenol-A modulates proliferation of human breast adenocarcinoma cells (MCF-7) by modulating apoptosis and cyclin-A
ea0032p502
Protective potential of 17-beta-estradiol on membrane linked functions in aging female rats: a behavioral, biochemical and ultrastructural study
ea0032p503
Effects of chlorobenzenes on the histamine (HA) activated arginine-vasopressin (AVP) release [ndash] from rat pituitary cells
ea0032p504
Rise of obesity incidence in ChNPP accident survivors is related to abnormal secretion of [alpha]-melanotropin
ea0032p505
Endocrine functions in premenopausal and postmenopausal women
ea0032p506
Peutz Jegher syndrome with multiple endocrinal failures
ea0032p507
Endocrine tumours and neoplasia
Heriditary forms of medullary carcinoma of the thyroid: about a new family
ea0032p508
Abstract unavailable
ea0032p509
Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993
ea0032p510
Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma
ea0032p511
Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions
ea0032p512
The embryonic transcription factor TBX1 is expressed in adult parathyroid cells and might be involved in parathyroid tumorigenesis
ea0032p513
Characterization and sub-cellular localization of somatostatin receptors in DU-145 and PC-3 human androgen-independent prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth
ea0032p514
Prevalence of P30L, V281L and P453S mutations of CYP21 gene in patients with nonfunctional adrenal incidentalomas
ea0032p515
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma
ea0032p516
The bone morphogenic proten 7 (Bmp7) plays a pro-tumorigenic role in pheochromocytoma
ea0032p517
Neuroendocrine tumours (NETs) of lung: new data on atypical carcinoid and large cell neuroendocrine carcinoma from a French-Italian multicentric study
ea0032p518
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids
ea0032p519
Assessment of fatal events in patients with radio-active iodine (RAI)-refractory differentiated thyroid cancer responsive to treatment with sorafenib
ea0032p520
Diagnosis of endogenous hyperinsulinism through arterial calcium stimulation with hepatic venous sampling
ea0032p521
Localization of pathological parathyroids in patients with thyroid abnormalities by PTH measurements in fine needle aspiration biopsy washouts
ea0032p522
Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT)
ea0032p523
The expression of SSTR dominant negative truncated variant sst5tMD4 influences the effects of SOM-230 on prostate cells in vitro
ea0032p524
Function and origin of tumour-associated fibroblasts (TAFs) in human parathyroid neoplasia
ea0032p525
Expression of FGF23, Klotho, CaSR, and PTHrP in carcinoma in situ and germ cell tumors of the testis: implications for testicular microlithiasis
ea0032p526
The clinical characteristics of primary hyperparathyroidism (PHPT) in patients with multiple endocrine neoplasia (MEN) type 1
ea0032p527
Establishment of patient-individual tumor models for endocrine tumors
ea0032p528
Familial malignant paraganglioma is long-term stabilized with the tyrosine-kinase inhibitor sunitinib
ea0032p529
Insulinoma: is enucleation a safe option?
ea0032p530
Long-term outcome after transarterial chemoembolization of hepatic metastases from neuroendocrine tumors
ea0032p531
Pituitary transforming gene 1 (PTTG1) expression in seminoma
ea0032p532
Polymorphisms of the glucocorticoid receptor gene, as phenotype modifiers in patients with hormonally inactive adrenal adenomas
ea0032p533
Mitochondrial ultrastructure in pseudohypoxic succinate dehydrogenase B and von Hippel-Lindau gene mutation derived pheochromocytomas and paragangliomas
ea0032p534
Adrenal lesions in patients with neuroendocrine tumors
ea0032p535
Association between expression of Ki-67, parafibromin, p27, and Rb protein and the biological behavior in parathyroid tumors
ea0032p536
RPS13 and cell cycle signaling pathways in pituitary tumorigenesis
ea0032p537
Incidental thyroid carcinomas in patients operated on for benign thyroid pathology, are there preoperative factors suggesting a higher risk?
ea0032p538
Involvement of PKC[Beta]; and PKC[Delta]; isoforms in TSH signaling pathway in thyroid cancer cell lines
ea0032p539
PKC[Delta]; plays an important in regulating human medullary thyroid carcinoma cell viability
ea0032p540
Sequential use of the kinase-inhibitors sorafenib and sunitinib in a patient affected with pluri-metastatic iodine-refractory follicular thyroid carcinoma
ea0032p541
Endogenous Cushing's syndrome: the Filipino clinical experience of 19 cases
ea0032p542
Hyperparathyroid jaw tumour syndrome
ea0032p543
Multimodal combination of interferon and loco-regional treatment for disease control in progressive metastatic pheochromocytoma/paraganglioma patients
ea0032p544
The metabolic complications in adrenal tumors: a retrospective study in 56 patients
ea0032p545
Malignant melanoma and prolactine imbalance
ea0032p546
Influence of iron deficiency on angiogenesis in melanoma patients
ea0032p547
Calcitonin comparison study of LIAISON XL vs IMMULITE 2000
ea0032p548
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids
ea0032p549
Steroid-induced psychosis as a manifestation of ectopic ACTH secretion from metastatic poorly differentiated neuroendocrine tumour
ea0032p550
Adrenal incidentalomas - a retrospective analysis for the period 2001-2011
ea0032p551
Androgen receptor expression in stromal and epithelial prostate cancer tissue specimens
ea0032p552
Prolactinoma and vestibular schwannoma: a very rare association
ea0032p553
The adverse effects in sub-optimal mitotane doses: a retrospective study
ea0032p554
Type 1 gastric endocrine tumors as an autoimmune disease, with emphasis to lymphocytic thyroiditis
ea0032p555
Acromegaly, primary hyperparathyroidism and meningioma - an unsual association in an asymptomatic patient with MEN1 syndrome
ea0032p556
Aggressive adreno-cortical carcinoma (ACC) associated with two rectal tumors (adenocarcinoma and neuro-endocrine) and somatic Kras mutation without microsatellite instability: is there a link?
ea0032p557
Patient-specific management of paragangliomas
ea0032p558
Malnutrition cause of Secondary Osteoporosis after surgical operation of Glucagonoma
ea0032p559
Clinical, biochemical, genetic and histological features of composite pheochromocytoma/ganglioneuroma adrenal tumors: a series of seven cases from two French academic centres
ea0032p560
Everolimus treatment in a series of patients with advanced neuroendocrine tumors
ea0032p561
Are hibernoma or lipoma a marker of type 1 multiple endocrine neoplasia (MEN1) aggressiveness?
ea0032p562
Malignant pheocromocytoma: vertebral metastasis 18 years after surgery. The importance of prolongued follow-up
ea0032p563
Gastroenteropancreatic neuroendocrine tumors: descriptive study in a reference Spanish hospital
ea0032p564
Extraordinary effect of ketoconazole in treatment of ACTH-dependent paraneoplastic Cushing syndrome
ea0032p565
An analysis of genotype--phenotype correlations and variable clinical expression in families with multiple endocrine neoplasia type 1
ea0032p566
Therapeutic difficulties in elderly patients with insulinoma
ea0032p567
Therapy with 177Lu marked somatostatin analogues in a case of pancreatic metastatic neuroendocrine tumor
ea0032p568
A case of pheochromocytoma that recognized as panic disorder before its exact diagnosis
ea0032p569
Various neuroendocrine tumors in a multiple endocrin neoplasia type 1 family with the same genetic background
ea0032p570
Visceral and tumour abormalities in subjects with acromegaly
ea0032p571
The clinical significance of tumor suppressor gene methylation, expression in nodular thyroid disease
ea0032p572
MEN2A syndrome: case presentation
ea0032p573
Female reproduction
Subcutaneous adipose tissue distribution and metabolic parameters in lean women with polycystic ovary syndrome
ea0032p574
Effect of resistin on LH and FSH stimulated steroidogenesis in porcine ovarian follicles during estrous cycle
ea0032p575
Relation of liver enzymes with indices of insulin resistance and hyperandrogenism in different PCOS phenotypes
ea0032p576
The hinge region of the lutropin receptor mediates different activation mechanisms: CG induces trans- and LH only cis-initialization
ea0032p577
AMHR2 polymorphism and risk for polycystic ovary syndrome: relationship to gonadotropin levels
ea0032p578
White blood cells levels and PCOS: direct and indirect relationship with insulin resistance, but not with hyperandogenemia
ea0032p579
Interactions among resistin and peroxisome proliferator activated receptor-[gamma] (PPAR-[gamma]) in porcine ovarian follicles.
ea0032p580
Differences in adrenocortical steroid response to ACTH in women with post-adolescent severe acne and PCOS
ea0032p581
Ovarian function is associated with obesity in very long-term female survivors of childhood cancer
ea0032p582
New endocrine and intracellular regulators of ovarian functions
ea0032p583
Deletions of TCF2 gene in Rokitansky syndrome (MRKH): a new candidate gene? About two new cases
ea0032p584
Thrombin generation in polycystic ovary syndrome: a marker of thrombosis
ea0032p585
The combination of genetic variants in the FSHR and FSHB genes affect serum FSH in women of reproductive age
ea0032p586
The hypothalamo--pituitary--adrenal axis sensitivity in women with polycystic ovary syndrome
ea0032p587
Value of lipid accumulation product for the assessment of metabolic syndrome in women with polycystic ovary syndrome
ea0032p588
The assessment of metabolic derangements including metabolic syndrome in relation to the degree of hyperandrogenism in women with polycystic ovary syndrome
ea0032p589
Gynecological aspects of prolactinoma
ea0032p590
Levonorgestrel inhibits human endometrial cell proliferation through the up-regulation of gap junctional intercellular communication via the increased expression of Connexin43 and the nuclear translocation of its Ser255 phosphorylation
ea0032p591
Overnight 1 mg dexamethasone androgen suppression test is useful diagnostic tool in hyperandrogenism.
ea0032p592
Low dose oral contraceptive use and the risk of thrombosis in polycystic ovary syndrome
ea0032p593
PCOS subphenotypes stratification reveals an apparent increase of metabolic syndrome frequency in patients with concomitant hyperandrogenism and menstrual irregularities
ea0032p594
Association of serum 25-hydroxyvitamin D and glucose levels in polycystic ovary syndrome
ea0032p595
Prevalence of prediabetes state is not equal in all phenotypes of polycystic ovary syndrome
ea0032p596
Metabolic features in patients with polycystic ovary syndrome (PCOS) during different stages of reproductive life
ea0032p597
Association of thyroid autoimmunity and thyroid dysfunction with obstetric antiphospholipid syndrome
ea0032p598
Inflammatory markers in polycystic ovarian syndrome and their association with cardiovascular risk factors
ea0032p599
The effect of metformin on pregnancy outcome among filipino women with polycystic ovary syndrome
ea0032p600
Flutamide-induced alterations in CYP17A1 gene expression and local testosterone synthesis in porcine luteal tissue - a new insight into androgens action during pregnancy
ea0032p601
Relation of adiponectin and leptin to antropometric and metabolic parameteres in women with polycystic ovaries syndrome
ea0032p602
PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenemia
ea0032p603
C-reactive protein and gestational diabetes mellitus
ea0032p604
Ovarian functions and polycystic ovary syndrome in women with type 1 diabetes mellitus
ea0032p605
Concordance study of pathological results of fertility hormones
ea0032p606
Main determinants of serum uric acid concentrations in polycystic ovary syndrome patients
ea0032p607
Vitamin D level in polycystic ovary syndrome patients is not different from healthy control in Turkish population
ea0032p608
Prevalence of polycystic ovary syndrome in infertile patients in Albania
ea0032p609
Association of advanced glycosylation end products receptor polymorphisms with coronary heart disease in postmenopausal women
ea0032p610
Association of gonadotroph pituitary macroadenoma and contiguous brain chordoma in a young woman with ovarian hyperstimulation syndrome
ea0032p611
Menstrual function in women of reproductive age with acromegaly
ea0032p612
Mechanisms of menstrual disorders in type1 diabetic women
ea0032p613
Mitochondrial function of pregnant women with subclinical hypothyroidism and gestational hypertension
ea0032p614
Hormonal disorders and breast diseases in adolescent girls
ea0032p615
Menstrual cycle length is associated with metabolic syndrome in young Korean women with oligomenorrhea
ea0032p616
Obstructive sleep apnea in Bulgarian patients with polycystic ovarian syndrome
ea0032p617
Plasma kisspeptin levels in polycystic ovary syndrome
ea0032p618
Relation of plasma kisspeptin levels with obesity and insulin resistance in polycystic ovary syndrome
ea0032p619
Potential discriminant factors for different pcos phenotypes
ea0032p620
Growth hormome IGF axis – basic
Delay stature and shox gene molecular abnormalities: about 4 families
ea0032p621
A comparison of the in vitro production of IGFs, IGFBP-4 and PAPP-A in cultures of visceral and subcutaneous adipose tissue fragments from obese subjects
ea0032p622
Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia
ea0032p623
Association between a common GH receptor polymorphism (exon 3-deletion), pre- and postnatal growth, serum insulin-like growth factor 1 and reproductive function in 838 healthy young males
ea0032p624
SNPs within the GH signaling pathway are associated with the fast, but not the long term, IGF1 response to GH replacement therapy in GH deficient adults
ea0032p625
Pilot study of nocturnal TSH surge in idiopathic short stature
ea0032p626
Preclinical characterisation of NNC0195-0092, a long-acting GH
ea0032p627
Sheehan's syndrome females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors
ea0032p628
Determinants of carotid intima media thickness in acromegaly patients
ea0032p629
First results from the PATRO adults study of omnitrope for the treatment of adult patients with GH deficiency
ea0032p630
GH therapy in Turner syndrome: growth rate indirectly correlated with age of therapy initiation
ea0032p631
Glucose metabolism abnormalities in a population of acromegalic patients
ea0032p632
Evaluation of LIAISON XL vs IMMULITE 2000 IGF1
ea0032p633
GH therapy: never say never; clinical case
ea0032p634
Silver-Russell syndrome about 15 cases and review of literature
ea0032p635
Neuroendocrine disorders and anomalies of median line: about two cases
ea0032p636
Male reproduction
KISS1R mutations in normosmic congenital hypogonadotropic hypogonadism: clinical evaluation of two families and molecular characterization of a novel mutation
ea0032p637
Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men
ea0032p638
Decreased expression of four memory genes in non-syndromic cryptorchid males
ea0032p639
Complete aromatase deficiency in four adult men: detection of a novel mutation and two known mutations in the CYP19A1 gene
ea0032p640
Mortality is increased in men treated with testosterone compared to age and sex-matched controls
ea0032p641
Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples
ea0032p642
Effects of iron therapy on pituitary gonadal axis and sperm parameters in adults with iron deficiency anemia (IDA)
ea0032p643
Endocrine disruptors target ATP binding cassette transporters in the blood-testis barrier and impair Leydig cell steroidogenesis
ea0032p644
Prenatal testosterone programming: ontogeny of changes in testis of fetal and prepubertal male sheep
ea0032p645
Androgen levels and sexual activity in young men (n=773), 20-29 years of age, a population based study. Odense Androgen Study
ea0032p646
Abstract unavailable
ea0032p647
Characterization of sumoylated proteins in human sperm
ea0032p648
Characterization of R31C GNRH1 mutation in congenital hypogonadotropic hypogonadism
ea0032p649
Abstract unavailable
ea0032p650
Sexual dysfunction in cirrhotic patients awaiting liver transplantation
ea0032p651
Fifteen years of experience with intramuscular testosterone undecanoate for substitution in male hypogonadism: beneficial effects on the metabolic syndrome and high safety profile
ea0032p652
Metabolic syndrome correlates with prostate volume and biochemical and ultrasound signs of prostate inflammation in male members of infertile couples
ea0032p653
Identification of vitamin D (VDR) and retinoic X (RXR) receptor in normal and neoplastic human reproductive tissues
ea0032p654
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation
ea0032p655
CATSPER calcium channels in human spermatozoa and their role in responsiveness to progesterone (P)
ea0032p656
Impaired masturbation induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction
ea0032p657
PSA as a marker of testosterone biological activity
ea0032p658
Effects of testosterone replacement therapy on hepcidin levels in young hypogonadal men
ea0032p659
D3 levels and hypogonadism in men
ea0032p660
Changes of neuroactive steroids caused by the smoking discontinuance
ea0032p661
Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012
ea0032p662
Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 6 years on hypogonadic patients
ea0032p663
Male pseudohermaphroditism Leydig cell hypoplasia
ea0032p664
Immunohistochemical detection of Prok1 and ProkR1 in normal testis and germ cell tumour tissue microarrays
ea0032p665
Endocrine disruptors in seminal fluid: bisphenol A, triclosan and benzophenone-3
ea0032p666
Sperm DNA fragmentation as assessed by TUNEL/PI: mean values in fertile men and intra individual variability
ea0032p667
The identification of pre-diabetes condition with ARIC algorithm, predicts long-term CV events in patients with erectile dysfunction
ea0032p668
Is pericentromeric inversion of the heterochromatic region of chromosome 9 involved in couple infertility?
ea0032p669
The hypothalamus-hypophysis-gonads axis in men in reproductive age with obesity and different pituitary adenomas
ea0032p670
A case of idiopathic hypogonadotropic hypogonadism which attained remission by LH and FSH treatment
ea0032p671
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction
ea0032p672
The role of testosterone augmentation in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) in improving functional recovery and hospital stay
ea0032p673
Fourty six, XX male sex reversal syndrome with infertility: a case report
ea0032p674
Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction
ea0032p675
Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors
ea0032p676
'It takes two to tango': the relational domain in a cohort of subjects with erectile dysfunction (ED)
ea0032p677
Neuroendocrinology
Genotype and phenotype characterization of the cohort of Italian patients with idiopathic central hypogonadism (ICH)
ea0032p678
DHEA enhances working memory and prevents distraction: behavioural and ERP evidence from an auditory-visual distraction paradigm
ea0032p679
High glucose induces hypogonadotropic hypogonadism by interfering with GPR54 signaling in the preoptic area of the hypothalamus
ea0032p680
Hypothalamic melanin-concentrating hormone influences liver and adipose lipid metabolism
ea0032p681
Hormonal therapy satisfaction is associated with better quality of life in transsexual persons
ea0032p682
The small GTPase Rab18 modulates neuroendocrine secretion by interacting with components of the microtubule-based secretory granule transport machinery
ea0032p683
Roles of kisspeptin partners, NKB and dynorphin, in the control of gonadotropin secretion: revisiting the KNDy paradigm
ea0032p684
Antipsychotic-induced hyperpolactinemia: clinical particulars and relation to sexual dysfunction
ea0032p685
Low carbohydrate/high fat energy intake decreases estrogen receptor alpha expression in the arcuate nucleus of the rat hypothalamus
ea0032p686
Digenic and oligogenic cases in a large cohort of idiopathic central hypogonadism (ICH) patients
ea0032p687
The characterization of sleep-wake pattern and its association with melatonin, as a marker of the circadian function of the suprachiasmatic nucleus, in craniopharyngioma patients
ea0032p688
Pituitary adenoma and associated tumors
ea0032p689
Iron overload impairs the migratory ability of a model of immature and migratory GnRH neurons
ea0032p690
The reproductive endocrine complications of antiepileptic drugs at woman's epilepsy
ea0032p691
DHEA and cortisol response to working memory
ea0032p692
Neuroprotective effects of estrogen rely on neuroglobin upregulation
ea0032p693
Diagnosis and management of patients presenting hyponatremia while receiving parenteral nutrition
ea0032p694
Des-acyl ghrelin acts directly and independently and counteracts acyl-ghrelin-induced neuronal activity in the central melanocortin system of rats
ea0032p695
Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population
ea0032p696
Impact of long acting somatostatin analogs vs successful surgery on glucose metabolism in Cretan acromegalic patients
ea0032p697
Prevalence and causes of hyponatremia in patients with endocrine disorders
ea0032p698
Acute exposure of Bisphenol-A from electronic gadgets does not induce oxidative stress in the rat's brain
ea0032p699
Oxytocin modulates olfaction-related behaviour and essential for onset of sexual behaviour in both sexes of mice
ea0032p700
Obestatin is associated to muscle strength, functional capacity and cognitive status in old women
ea0032p701
Copeptin for subtype differentiation of abnormal vasopressin release in SIADH: reclassification and characterization of a novel subtype
ea0032p702
Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome
ea0032p703
Evaluation of GH deficiency and central adrenal insufficiency in patients following craniospinal irradiation in young ages: comparison between the glucagon stimulation test and the insulin tolerance test
ea0032p704
Diurnal melatonin profile in patients with acromegaly
ea0032p705
Comparative analysis of the hormonal, MRI and morphological characteristics of patients with Cushing's disease remission and no remission after neurosurgical treatment
ea0032p706
Prevalence and clinical significance of hook-effect and macroprolactinaemia phenomenons in patients with prolactinomas
ea0032p707
Hyponatremia in the emergency room: characteristics, and initial diagnostic approach
ea0032p708
Modulation of Na+/K+-ATPase activity of rat brain synaptosome by norepinepherine and serotonin
ea0032p709
Adulthood germ cell tumor: a case report
ea0032p710
Infrasellar gangliocytoma causing cushing's disease: a case report
ea0032p711
Effects of GH therapy in carbohydrate metabolism in spanish adults with GH deficiency
ea0032p712
Clinical case of silent corticotropinoma
ea0032p713
Central diabetes insipidus, as the first sign of Langerhans cell histiocytosis in an adult
ea0032p714
RET codon 618 mutation is the most frequent genotype in saudi families with multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma
ea0032p715
Neurological manifestations of Vitamin D deficiency, is there any significant clinical correlation?
ea0032p716
Craniopharyngioma -- a diagnosis not to be missed
ea0032p717
Features of family inheritance in patients of non-functional pituitary adenomas in Uzbekistan
ea0032p718
Abstract unavailable
ea0032p718.1
Nuclear receptors and signal transduction
The nuclear corepressor NCoR is an essential mediator of the anti-tumorigenic and anti-metastatic actions of the thyroid hormone receptor
ea0032p719
Coordination of 17[beta]-estradiol-dependent cell proliferation requires diverse post-translational modifications
ea0032p720
Non-proteolytic ubiquitin-based signalling regulates estrogen receptor [alpha] activities
ea0032p721
The thyroid hormone receptors inhibit invasive and fibrotic responses to TGF[beta] by transcriptional cross-talk with smad-transcription factors
ea0032p722
5/6 Nephrectomy reduces muscle mitochondria in mice as to decrease exercise endurance associated with further exacerbation by dietary protein
ea0032p723
Effects of Tribulus terrestris on immune function in over-trained rats and its mechanism: the role of glucocorticoid and glucocorticoid receptor
ea0032p724
Nuclear receptor 'master' coactivators of physiology and pathology
ea0032p725
Obesity
The lack of Nur77 affects energy and glucose metabolism in females fed on high fat diet
ea0032p726